International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.1274545
Original Research Article
Study to Compare Efficacy of Laparoscopic Anterior Mesh Rectopexy and Posterior Suture Rectopexy in Cases of Complete Rectal Prolapse - A Prospective Observational Study
Published
Nov. 20, 2024
Abstract

Background: Laparoscopic rectopexy is an established treatment for complete rectal prolapse. This study aimed to compare the short-term outcomes of laparoscopic posterior suture rectopexy (PSR) and anterior mesh rectopexy (AMR).Methods: A total of 30 patients with complete rectal prolapse were prospectively enrolled and randomly assigned to undergo either PSR (n=16) or AMR (n=14). Demographic data, clinical history, intra-operative findings, hospital stay, post-operative bowel movements, and complications were recorded and analyzed.Results: The mean age was 50.44±17.28 years in the PSR group and 56.44±12.50 years in the AMR group (p>0.05). The mean intra-operative blood loss was 23.44±3.9 ml in the PSR group and 20.71±3.3 ml in the AMR group (p=0.053). The mean duration of surgery was 85.75±7.5 min in the PSR group and 92.0±9.9 min in the AMR group (p=0.062). The mean hospital stay was 3.0±0.0 days in the PSR group and 4.0±0.0 days in the AMR group. In the PSR group, 62.5% of patients had their first bowel movement on postoperative day 1, compared to 21.4% in the AMR group (p=0.059). There were no cases of new-onset constipation in either group. One patient (7.1%) in the AMR group had recurrence, and one patient (7.1%) had retrograde ejaculation (p=0.467).Conclusion: PSR and AMR are safe and effective techniques for the treatment of complete rectal prolapse, with comparable short-term outcomes. The PSR group showed a trend towards earlier return of bowel function. Further studies with larger sample sizes and longer follow-up are needed to validate these findings.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1144 Views
365 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved